NewEdge Advisors’s Cidara Therapeutics CDTX Stock Holding History

NewEdge Advisors’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7	Closed	-$1.55K	–	4183
2025 Q4	$1.55K	Buy	+7	New	+$1.13K	﹤0.01%	3926

NewEdge Advisors's CDTX Position: Q1 2026 in Review

NewEdge Advisors sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 7 shares — an estimated $1.55K sold.

NewEdge Advisors first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $1.55K in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

NewEdge Advisors reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
NewEdge Advisors sold 7 Cidara Therapeutics shares in Q1 2026, an estimated $1.55K.
NewEdge Advisors first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
NewEdge Advisors's Cidara Therapeutics position peaked at $1.55K in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.